155 related articles for article (PubMed ID: 30241109)
1. European Academy of Cancer Sciences - position paper.
Adami HO; Berns A; Celis JE; de Vries E; Eggermont A; Harris A; Zur Hausen H; Pelicci PG; Ringborg U
Mol Oncol; 2018 Nov; 12(11):1829-1837. PubMed ID: 30241109
[TBL] [Abstract][Full Text] [Related]
2. Towards a cancer mission in Horizon Europe: recommendations.
Berns A; Ringborg U; Celis JE; Heitor M; Aaronson NK; Abou-Zeid N; Adami HO; Apostolidis K; Baumann M; Bardelli A; Bernards R; Brandberg Y; Caldas C; Calvo F; Dive C; Eggert A; Eggermont A; Espina C; Falkenburg F; Foucaud J; Hanahan D; Helbig U; Jönsson B; Kalager M; Karjalainen S; Kásler M; Kearns P; Kärre K; Lacombe D; de Lorenzo F; Meunier F; Nettekoven G; Oberst S; Nagy P; Philip T; Price R; Schüz J; Solary E; Strang P; Tabernero J; Voest E
Mol Oncol; 2020 Aug; 14(8):1589-1615. PubMed ID: 32749074
[TBL] [Abstract][Full Text] [Related]
3. Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023.
Ringborg U; von Braun J; Celis J; Baumann M; Berns A; Eggermont A; Heard E; Heitor M; Chandy M; Chen CJ; Costa A; De Lorenzo F; De Robertis EM; Dubee FC; Ernberg I; Gabriel M; Helland Å; Henrique R; Jönsson B; Kallioniemi O; Korbel J; Krause M; Lowy DR; Michielin O; Nagy P; Oberst S; Paglia V; Parker MI; Ryan K; Sawyers CL; Schüz J; Silkaitis K; Solary E; Thomas D; Turkson P; Weiderpass E; Yang H
Mol Oncol; 2024 Feb; 18(2):245-279. PubMed ID: 38135904
[TBL] [Abstract][Full Text] [Related]
4. Towards a mission-oriented approach to cancer in Europe: an unmet need in cancer research policy.
Celis JE; Heitor M
Mol Oncol; 2019 Mar; 13(3):502-510. PubMed ID: 30657635
[TBL] [Abstract][Full Text] [Related]
5. Anniversary Oncology Days in Paris.
Baltaga R
Exp Oncol; 2023 Dec; 45(3):273-274. PubMed ID: 38186028
[TBL] [Abstract][Full Text] [Related]
6. Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century.
Calvo F; Apolone G; Baumann M; Caldas C; Celis JE; de Lorenzo F; Ernberg I; Ringborg U; Rowell J; Tabernero J; Voest E; Eggermont A
Eur J Cancer; 2018 Nov; 103():155-159. PubMed ID: 30241002
[TBL] [Abstract][Full Text] [Related]
7. Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.
Kehrloesser S; Oberst S; Westerhuis W; Wendler A; Wind A; Blaauwgeers H; Burrion JB; Nagy P; Saeter G; Gustafsson E; De Paoli P; Lovey J; Lombardo C; Philip T; de Valeriola D; Docter M; Boomsma F; Saghatchian M; Svoboda M; Philip I; Monetti F; Hummel H; McVie G; Otter R; van Harten W
Mol Oncol; 2021 May; 15(5):1277-1288. PubMed ID: 33734563
[TBL] [Abstract][Full Text] [Related]
8. Cancer Core Europe: A translational research infrastructure for a European mission on cancer.
Eggermont AMM; Apolone G; Baumann M; Caldas C; Celis JE; de Lorenzo F; Ernberg I; Ringborg U; Rowell J; Tabernero J; Voest E; Calvo F
Mol Oncol; 2019 Mar; 13(3):521-527. PubMed ID: 30657633
[TBL] [Abstract][Full Text] [Related]
9. Translational cancer research - a coherent cancer research continuum.
Ringborg U
Mol Oncol; 2019 Mar; 13(3):517-520. PubMed ID: 30657250
[TBL] [Abstract][Full Text] [Related]
10. Bridging research and clinical care - the comprehensive cancer centre.
Oberst S
Mol Oncol; 2019 Mar; 13(3):614-618. PubMed ID: 30628155
[TBL] [Abstract][Full Text] [Related]
11. The Porto European Cancer Research Summit 2021.
Ringborg U; Berns A; Celis JE; Heitor M; Tabernero J; Schüz J; Baumann M; Henrique R; Aapro M; Basu P; Beets-Tan R; Besse B; Cardoso F; Carneiro F; van den Eede G; Eggermont A; Fröhling S; Galbraith S; Garralda E; Hanahan D; Hofmarcher T; Jönsson B; Kallioniemi O; Kásler M; Kondorosi E; Korbel J; Lacombe D; Carlos Machado J; Martin-Moreno JM; Meunier F; Nagy P; Nuciforo P; Oberst S; Oliveiera J; Papatriantafyllou M; Ricciardi W; Roediger A; Ryll B; Schilsky R; Scocca G; Seruca R; Soares M; Steindorf K; Valentini V; Voest E; Weiderpass E; Wilking N; Wren A; Zitvogel L
Mol Oncol; 2021 Oct; 15(10):2507-2543. PubMed ID: 34515408
[TBL] [Abstract][Full Text] [Related]
12. Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).
Saghatchian M; Hummel H; Otter R; de Valeriola D; Van Harten W; Paradiso A; Koot B; Ringborg U; Tursz T;
Tumori; 2008; 94(2):164-71. PubMed ID: 18564602
[TBL] [Abstract][Full Text] [Related]
13. Quality-assured research environments for translational cancer research.
Berns A
Mol Oncol; 2019 Mar; 13(3):543-548. PubMed ID: 30628170
[TBL] [Abstract][Full Text] [Related]
14. From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021-lessons learned and implications.
Celis J; Ringborg U
Mol Oncol; 2024 Apr; 18(4):785-792. PubMed ID: 38468400
[TBL] [Abstract][Full Text] [Related]
15. European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
Lawler M; Davies L; Oberst S; Oliver K; Eggermont A; Schmutz A; La Vecchia C; Allemani C; Lievens Y; Naredi P; Cufer T; Aggarwal A; Aapro M; Apostolidis K; Baird AM; Cardoso F; Charalambous A; Coleman MP; Costa A; Crul M; Dégi CL; Di Nicolantonio F; Erdem S; Geanta M; Geissler J; Jassem J; Jagielska B; Jonsson B; Kelly D; Kelm O; Kolarova T; Kutluk T; Lewison G; Meunier F; Pelouchova J; Philip T; Price R; Rau B; Rubio IT; Selby P; Južnič Sotlar M; Spurrier-Bernard G; van Hoeve JC; Vrdoljak E; Westerhuis W; Wojciechowska U; Sullivan R
Lancet Oncol; 2023 Jan; 24(1):e11-e56. PubMed ID: 36400101
[TBL] [Abstract][Full Text] [Related]
16. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
17. A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.
Celis JE; Pavalkis D
Mol Oncol; 2017 Dec; 11(12):1661-1672. PubMed ID: 29024497
[TBL] [Abstract][Full Text] [Related]
18. Education aimed at increasing international collaboration and decreasing inequalities.
Ernberg I
Mol Oncol; 2019 Mar; 13(3):648-652. PubMed ID: 30677237
[TBL] [Abstract][Full Text] [Related]
19. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
20. Assessing excellence in translational cancer research: a consensus based framework.
Rajan A; Caldas C; van Luenen H; Saghatchian M; van Harten WH
J Transl Med; 2013 Oct; 11():274. PubMed ID: 24168073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
